SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Hawthorn Pharmaceuticals, Inc. and the University of Pittsburgh Sign Exclusive Global Licensing Agreement of CSPG4 Specific Monoclonal Antibodies